Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance

OBJECTIVE: Plasma glycated CD59 (pGCD59) is an emerging biomarker in diabetes. We assessed whether pGCD59 could predict the following: the results of the glucose challenge test (GCT) for screening of gestational diabetes mellitus (GDM) (primary analysis); and the diagnosis of GDM and prevalence of l...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Pamela, Luque-Fernandez, Miguel A., Vaidya, Anand, Ma, Dongdong, Sahoo, Rupam, Chorev, Michael, Zera, Chloe, McElrath, Thomas F., Williams, Michelle A., Seely, Ellen W., Halperin, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Novel Communications in Diabetes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481979/
https://www.ncbi.nlm.nih.gov/pubmed/28450368
http://dx.doi.org/10.2337/dc16-2598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481979/
https://www.ncbi.nlm.nih.gov/pubmed/28450368
http://dx.doi.org/10.2337/dc16-2598

Ejemplares similares